FDA NDC
TAKHZYRO
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 47783-645
- Proprietary name
- TAKHZYRO
- Nonproprietary name
- lanadelumab-flyo
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Dosage form
- SOLUTION
- Strength
- 150 mg/mL
HCPCS J1290 Billable units per 11-digit NDC: 30.